Deep learning predicts HER2 status in invasive breast cancer from multimodal ultrasound and MRI. Biomol Biomed [Internet]. 2025 May 16 [cited 2025 May 21];. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/12475